Stock listing

NASDAQ:KNTE Kinnate Biopharma Inc Stock

Follow Kinnate Biopharma Inc into a list and get an email when it puts out news.

Last close · NASDAQ:KNTE

$2.65 USD

Close on Apr 3, 2024 · No longer trades

Dec 3, 2020 to last close -93.2% · weekly closes, Dec 3, 2020 – Apr 3, 2024
Lowest – highest close
$1.07 – $45.25 USDSince Dec 3, 2020 · lowest Oct 25, 2023 · highest Dec 9, 2020

Delisted NASDAQ:KNTE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:KNTE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dean Mitchell
Other companies: Praxis Precision Medicines, Inc. (Chairman of the Board · Since at least Oct 15, 2020); Theravance Biopharma, Inc. (Director · Since at least Apr 30, 2019); Precigen, Inc. (Director · Mar 8, 2020 – Mar 14, 2024 · Past); ImmunoGen Inc (Director · Mar 31, 2019 – Feb 12, 2024 · Past)
Director · Dec 2, 2020 – Apr 3, 2024 · Past
Melissa Epperly
Other companies: Roivant Sciences Ltd. (Director · Since at least Jun 29, 2022); Nautilus Biotechnology, Inc. (Director · Since at least Jun 9, 2021); Zentalis Pharmaceuticals, Inc. (Chief Financial Officer · Apr 3, 2020 – Feb 12, 2024 · Past)
Director · Dec 2, 2020 – Apr 3, 2024 · Past
Neha Krishnamohan
Other companies: Latigo Biotherapeutics, Inc. (Chief Financial Officer and Chief Business Officer · Since at least Aug 6, 2026); Artiva Biotherapeutics, Inc. (Chief Financial Officer · Since at least Jul 18, 2024); Arcutis Biotherapeutics, Inc. (Director · Since at least Sep 2, 2022)
CHIEF FINANCIAL OFFICER · Jun 7, 2021 – Apr 3, 2024 · Past
Mark Meltz
Other companies: Lyell Immunopharma, Inc. (General Counsel and Corporate Secretary · Since at least Jun 9, 2025); Audentes Therapeutics Inc (SVP, General Counsel · Mar 28, 2019 – Jan 15, 2020 · Past)
COO GENERAL COUNSEL SECRETARY · Dec 2, 2020 – Apr 3, 2024 · Past
Nima Farzan
Other companies: Latigo Biotherapeutics, Inc. (President and CEO, Director · Since at least Aug 6, 2026); Keros Therapeutics, Inc. (Director · Since at least May 30, 2024)
CHIEF EXECUTIVE OFFICER, Director · Apr 3, 2024 – Apr 3, 2024 · Past
Helen Sabzevari
Other companies: Precigen, Inc. (President and CEO · Since at least Nov 27, 2017)
Director · Jun 24, 2021 – Apr 3, 2024 · Past
Eric Anthony MurphyChief Scientific Officer · Dec 2, 2020 – Feb 12, 2021 · Past
Keith T FlahertyDirector · Apr 3, 2024 – Apr 3, 2024 · Past
Richard Thomas WilliamsCHIEF MEDICAL OFFICER · Dec 2, 2020 – Mar 1, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Kinnate Biopharma Inc.